PEOPLE - NeuroVasx (US) makes appointment:
This article was originally published in Clinica
NeuroVasx, a US development stage company focused on developing catheter and implant technologies, has elected Lloyd Armstrong to its board of directors. Mr Armstrong is president and CEO of the Pfizer subsidiary American Medical Systems.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.